Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 42

1.

Genome-wide expression profiling of the response to polyene, pyrimidine, azole, and echinocandin antifungal agents in Saccharomyces cerevisiae.

Agarwal AK, Rogers PD, Baerson SR, Jacob MR, Barker KS, Cleary JD, Walker LA, Nagle DG, Clark AM.

J Biol Chem. 2003 Sep 12;278(37):34998-5015. Epub 2003 Jun 24.

2.

History of the development of azole derivatives.

Maertens JA.

Clin Microbiol Infect. 2004 Mar;10 Suppl 1:1-10. Review.

3.

[Drug discovery based on microarray].

Kuhara S, Tashiro K, Muta S.

Nihon Yakurigaku Zasshi. 2002 Nov;120(1):47P-50P. Review. Japanese.

PMID:
12491777
4.

Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections.

Moen MD, Lyseng-Williamson KA, Scott LJ.

Drugs. 2009;69(3):361-92. doi: 10.2165/00003495-200969030-00010. Review.

PMID:
19275278
5.

Yeast on drugs: Saccharomyces cerevisiae as a tool for anticancer drug research.

Menacho-Márquez M, Murguía JR.

Clin Transl Oncol. 2007 Apr;9(4):221-8. Review.

PMID:
17462974
6.

Clinical relevance of mechanisms of antifungal drug resistance in yeasts.

Sanglard D.

Enferm Infecc Microbiol Clin. 2002 Nov;20(9):462-9; quiz 470, 479. Review.

PMID:
12425880
7.

Chemical-genetic approaches for exploring the mode of action of natural products.

Lopez A, Parsons AB, Nislow C, Giaever G, Boone C.

Prog Drug Res. 2008;66:237, 239-71. Review.

PMID:
18416308
8.

Genomic and genetic approaches for the identification of antifungal drug targets.

Agarwal AK, Xu T, Jacob MR, Feng Q, Li XC, Walker LA, Clark AM.

Infect Disord Drug Targets. 2008 Mar;8(1):2-15. Review.

PMID:
18473903
9.

Antifungals: mechanism of action and resistance, established and novel drugs.

Georgopapadakou NH.

Curr Opin Microbiol. 1998 Oct;1(5):547-57. Review.

PMID:
10066533
10.

Antifungal drugs on the horizon.

Hay RJ.

J Am Acad Dermatol. 1994 Sep;31(3 Pt 2):S82-6. Review.

PMID:
8077515
11.

Applications of yeast in drug discovery.

Ma D.

Prog Drug Res. 2001;57:117-62. Review.

PMID:
11728000
12.

Global analysis of gene expression in yeast.

Horak CE, Snyder M.

Funct Integr Genomics. 2002 Sep;2(4-5):171-80. Epub 2002 Jul 10. Review.

PMID:
12192590
13.

Toxicogenomics using yeast DNA microarrays.

Yasokawa D, Iwahashi H.

J Biosci Bioeng. 2010 Nov;110(5):511-22. doi: 10.1016/j.jbiosc.2010.06.003. Epub 2010 Jul 10. Review.

PMID:
20624688
14.
15.

Mechanisms of fungal resistance: an overview.

Balkis MM, Leidich SD, Mukherjee PK, Ghannoum MA.

Drugs. 2002;62(7):1025-40. Review.

PMID:
11985489
16.

[Systematic analysis of Saccharomyces cerevisiae genome: gene network and protein-protein interaction network].

Ito T, Tashiro K, Kuhara T.

Tanpakushitsu Kakusan Koso. 2001 Dec;46(16 Suppl):2407-13. Review. Japanese. No abstract available.

PMID:
11802402
17.

Systemic antifungal agents. What is in the pipeline?

Kauffman CA.

Drugs R D. 1999 Feb;1(2):153-9. Review.

PMID:
10566012
18.

Genomics strategies for antifungal drug discovery--from gene discovery to compound screening.

Willins DA, Kessler M, Walker SS, Reyes GR, Cottarel G.

Curr Pharm Des. 2002;8(13):1137-54. Review.

PMID:
12052224
19.

Antifungal agents: mechanisms of action.

Odds FC, Brown AJ, Gow NA.

Trends Microbiol. 2003 Jun;11(6):272-9. Review.

PMID:
12823944
20.

Translation elongation-3-like factors: are they rational antifungal targets?

Sturtevant J.

Expert Opin Ther Targets. 2002 Oct;6(5):545-53. Review.

PMID:
12387678

Supplemental Content

Support Center